STRS Ohio’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-78
Closed -$12K 2316
2020
Q4
$12K Hold
78
﹤0.01% 2102
2020
Q3
$8K Hold
78
﹤0.01% 2144
2020
Q2
$9K Hold
78
﹤0.01% 2107
2020
Q1
$6K Hold
78
﹤0.01% 1972
2019
Q4
$22K Hold
78
﹤0.01% 1968
2019
Q3
$14K Hold
78
﹤0.01% 2004
2019
Q2
$30K Sell
78
-80
-51% -$33.7K ﹤0.01% 1990
2019
Q1
$73K Hold
158
﹤0.01% 1836
2018
Q4
$75K Hold
158
﹤0.01% 1817
2018
Q3
$107K Hold
158
﹤0.01% 1826
2018
Q2
$107K Buy
+158
New +$102K ﹤0.01% 1848

Other funds holding ELOX

STRS Ohio's ELOX Position: Q1 2021 in Review

STRS Ohio sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q1 2021, closing a stake of 78 shares — an estimated $12K sold.

STRS Ohio first reported a position in ELOX in Q2 2018 and held it in 11 quarters. The position peaked at $107K in Q3 2018. 37 funds tracked by Wall St. Rank hold ELOX as of Q1 2021.

  • STRS Ohio reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • STRS Ohio sold 78 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q1 2021, an estimated $12K.
  • STRS Ohio first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 11 quarters.
  • STRS Ohio's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $107K in Q3 2018.
  • 37 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q1 2021.

Based on STRS Ohio's 13F filing for Q1 2021, filed 23 Apr 2021.